TG THERAPEUTICS, INC. Annual Interest Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tg Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2011 to 2023.
  • Tg Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $2.29M, a 19.6% decline year-over-year.
  • Tg Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $12.1M, a 16.3% increase year-over-year.
  • Tg Therapeutics, Inc. annual Interest Expense for 2023 was $12.6M, a 23.8% increase from 2022.
  • Tg Therapeutics, Inc. annual Interest Expense for 2022 was $10.2M, a 80.8% increase from 2021.
  • Tg Therapeutics, Inc. annual Interest Expense for 2021 was $5.64M, a 10.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.6M +$2.42M +23.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $10.2M +$4.55M +80.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $5.64M -$691K -10.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $6.33M +$1.04M +19.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $5.29M +$4.41M +503% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $877K +$32K +3.79% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $845K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2015 $973K +$42K +4.52% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-15
2014 $931K -$22.2K -2.33% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-15
2013 $953K +$47.1K +5.21% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $906K +$899K +12662% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-07
2011 $7.1K Jan 1, 2011 Dec 31, 2011 10-K 2013-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.